Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dactinomycin and Vitamin D

supplement:

Vitamin D

Research Papers that Mention the Interaction

Small doses of mithramycin inhibit bone resorption; dactinomycin and other RNA inhibitors block the action of vitamin D in vitro.
Clinical pharmacology and therapeutics  •  1971  |  View Paper
These protective effects of vitamin D3 were completely attenuated by intracerebroventricular injection of transcription inhibitor Actinomycin D and significantly inhibited by small interfering ribonucleic acid (siRNA) for vitamin D receptor and OPN in Pre-SAH + VitD3 rats.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism  •  2017  |  View Paper
This suppression was observed within 24 h and lasted for at least 48 h. The … starting at 10(-9) mol/L and saturated at 10(-8) mol/L. The vitamin D3 suppression of HES-… blocked by actinomycin D as well as cycloheximide, suggesting the …, which requires new protein synthesis.
Bone  •  1997  |  View Paper
Actinomycin D (intramuscular, 100 micrograms/200 g of body wt) together with ergocalciferol (120 micrograms/200 g of body wt) reduced protein kinase C activity by 51% 24 hr after injection.
The international journal of biochemistry & cell biology  •  1996  |  View Paper
The increase in alkaline phosphatase activity following simultaneous administration of vitamin D3 and zinc was significantly inhibited by treatment with cycloheximide, actinomycin D , or mitomycin C. Also, the increase in DNA content was completely inhibited by mitomycin C treatment.
Acta endocrinologica  •  1986  |  View Paper
Inhibition of vitamin D responses by actinomycin D suggests the involvement of gene activation in the sterol's action of raising intestinal transport activities.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  •  1982  |  View Paper
Actinomycin D or cycloheximide given in vivo reduces the 25-hydroxyvitamin D3 -24-hydroxylase activity rapidly which suggests that the turnover of the enzyme and its messenger RNA is rapid (1- and 5-h half-life, respectively).
Archives of biochemistry and biophysics  •  1975  |  View Paper
A more recent alternative hypothesis suggested that actinomycin D blocked the biological response to calciferol by inhibiting the mandatory metabolism of cholecalciferol to 1,25-dihydroxycholecalciferol.
Actinomycin D was found to inhibit calcium transport stimulated by cholecalciferol or its metabolites without inhibiting their metabolism or localization in the target tissue, the intestinal mucosa.
Archives of biochemistry and biophysics  •  1973  |  View Paper
While the response of intestinal transport to physiological amounts of 25-hydroxycholecalciferol is blocked by actinomycin D , the response of intestinal calcium transport to 1,25-dihydroxycholecalciferol is insensitive to the antibiotic.
Proceedings of the National Academy of Sciences of the United States of America  •  1971  |  View Paper
Actinomycin D inhibited this vitamin D3 action in microsomes and supernatants.
The Journal of vitaminology  •  1970  |  View Paper
Show More